BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34987057)

  • 1. Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability.
    Liu X; Li Z; Wang Z; Liu F; Zhang L; Ke J; Xu X; Zhang Y; Yuan Y; Wei T; Shan Q; Chen Y; Huang W; Gao J; Wu N; Chen F; Sun L; Qiu Z; Deng Y; Wang X
    Cancer Res; 2022 Mar; 82(5):791-804. PubMed ID: 34987057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
    Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
    Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.
    Nagarajan S; Rao SV; Sutton J; Cheeseman D; Dunn S; Papachristou EK; Prada JG; Couturier DL; Kumar S; Kishore K; Chilamakuri CSR; Glont SE; Archer Goode E; Brodie C; Guppy N; Natrajan R; Bruna A; Caldas C; Russell A; Siersbæk R; Yusa K; Chernukhin I; Carroll JS
    Nat Genet; 2020 Feb; 52(2):187-197. PubMed ID: 31913353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
    Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
    Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic
    Walter DM; Venancio OS; Buza EL; Tobias JW; Deshpande C; Gudiel AA; Kim-Kiselak C; Cicchini M; Yates TJ; Feldser DM
    Cancer Res; 2017 Apr; 77(7):1719-1729. PubMed ID: 28202515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice.
    Mathur R; Alver BH; San Roman AK; Wilson BG; Wang X; Agoston AT; Park PJ; Shivdasani RA; Roberts CW
    Nat Genet; 2017 Feb; 49(2):296-302. PubMed ID: 27941798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
    Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
    Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
    [No Abstract]   [Full Text] [Related]  

  • 9. ARID1A loss in cancer: Towards a mechanistic understanding.
    Mathur R
    Pharmacol Ther; 2018 Oct; 190():15-23. PubMed ID: 29730444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
    Kelso TWR; Porter DK; Amaral ML; Shokhirev MN; Benner C; Hargreaves DC
    Elife; 2017 Oct; 6():. PubMed ID: 28967863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications.
    Xu W; Dong H; Ru G; Zhao M
    Diagn Pathol; 2022 Feb; 17(1):22. PubMed ID: 35125107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Guan B; Wang TL; Shih IeM
    Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF.
    Chandler RL; Brennan J; Schisler JC; Serber D; Patterson C; Magnuson T
    Mol Cell Biol; 2013 Jan; 33(2):265-80. PubMed ID: 23129809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications.
    Jin F; Yang Z; Shao J; Tao J; Reißfelder C; Loges S; Zhu L; Schölch S
    Trends Mol Med; 2023 Aug; 29(8):646-658. PubMed ID: 37179132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of the AT-Rich Interaction Domain 1A Gene (
    Li JJ; Lee CS
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
    Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
    Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arid1a restrains Kras-dependent changes in acinar cell identity.
    Livshits G; Alonso-Curbelo D; Morris JP; Koche R; Saborowski M; Wilkinson JE; Lowe SW
    Elife; 2018 Jul; 7():. PubMed ID: 30014851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
    Tsuruta S; Kohashi K; Yamada Y; Fujiwara M; Koga Y; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Cancer Sci; 2020 Mar; 111(3):1008-1019. PubMed ID: 31922331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-PanIN-seq unveils that
    Liu S; Cao W; Niu Y; Luo J; Zhao Y; Hu Z; Zong C
    Elife; 2021 May; 10():. PubMed ID: 33983114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.